Almac Pharma Services' response to the Coronavirus (COVID-10) Outbreak

 
Home /

Almac Pharma Services’ response to the Coronavirus (COVID-10) Outbreak

Upon declaration by the World Health Organisation (WHO) of the COVID-19 (Coronavirus) pandemic in 2020, Almac Pharma Services has been continually monitoring the situation relating to the global outbreak to ensure the health and well-being of employees, the minimisation of risk to business operations, as well as management of resources, to ensure our capacities and service levels are maintained for clients.

Almac Pharma Services’ Continual Monitoring of the Situation

  • Daily assessment of the global situation is occurring to establish the impact on business activities.
  • Command teams consisting of Sr. Directors/Managers/Executives have been established at our facilities. These teams meet frequently to proactively develop contingencies for any suspected transmissions of the virus and/or business impact at any of our facilities.
  • Almac Pharma Services continually reviews how we sustain business operations and how to minimise any potential impacts. Due to the nature of Almac Pharma Services’ work, our employees have access to all the necessary tools and resources while working in the office, and from home- This is to meet the expectation that business should continue as normal, and during normal business hours.

The wellbeing of our employees is Almac’s number one priority therefore during this time we appreciate your ongoing support and understanding as we work together to manage this challenging situation.

Our customer support teams will keep in regular contact with you as to the status of your projects, but should you have any additional concerns regarding your product or protocol, please do not hesitate to contact your client representative.

Click here to read Almac Group’s Response to the Coronavirus (COVID-19) Outbreak. 

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies